Engineered autologous cell therapy

Engineered autologous cell therapy

Click here to see larger versions of the illustrations in the portfolio section.


Engineered Autologous Cell Therapy

A patient's blood T cells are genetically modified to express receptor molecules in order that these T cells eradicate cancer cells. In the top figure, T cells are engineered to express the chimeric antigen receptor (CAR); in the bottom figure the T cell receptor (TCR).

For more information please visit:

[Engineered Autologous Cell Therapy, Kite Pharma, Inc.]

Created for
Kite Pharma, Inc., Santa Monica (CA)

April 15, 2014

© 2014 Kite Pharma, Inc. All rights reserved.


[See all news]